Revisiting the Medical Management of Parkinson's Disease: Levodopa versus Dopamine Agonist
The optimal treatment strategy for Parkinson's disease has been debated for decades. The introduction of levodopa (LD) treatment is frequently delayed because of theoretical concerns about its toxicity or the risk of drug-induced motor complications. These concerns have resulted in “LD phobia”...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Bentham Science Publishers
2016
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876591/ |